Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. J. Pharm. Sci. (Online) ; 58: e19958, 2022. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1383955

Résumé

Abstract The ß-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-ß-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine


Sujets)
Triazines/effets indésirables , Techniques in vitro/méthodes , Douleur , Acetylcholinesterase/pharmacologie , Butyrylcholine esterase/pharmacologie , Butyryl-thiocholine/effets indésirables , Carbolines/agonistes , Anticholinestérasiques/administration et posologie , Simulation de docking moléculaire/instrumentation
SÉLECTION CITATIONS
Détails de la recherche